Kazatchkine
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hemophilia Treatment and Research
- Immunology top 10%
- Complement system in diseases
Papers in
-
- Immunodeficiency and Autoimmune Disorders 5
- Complement system in diseases 4
- T-cell and B-cell Immunology 3
-
- Blood groups and transfusion 4
- Hemophilia Treatment and Research 2
- Platelet Disorders and Treatments 2
- Co-authors
- Fearon Dt (2 shared papers)Austen Kf (1 shared paper)F Maillet (2 shared papers)A Carpentier (1 shared paper)Evelyne Fischer (1 shared paper)Crh Wildevuur (1 shared paper)Béatrice Descamps‐Latscha (1 shared paper)N Hinglais (2 shared papers)
- Journals
- Clinical Nephrology (1 paper)Scandinavian Journal of Immunology (1 paper)PubMed (17 papers)
- Partner nations
- FranceNetherlands
In The Last Decade
Kazatchkine
19 papers receiving 680 citations
Peers
Comparison fields: 5 of 79
- Hematology 193
- Immunology 345
- Nephrology 66
- Microbiology 35
- Genetics 57
Countries citing papers authored by Kazatchkine
This map shows the geographic impact of Kazatchkine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazatchkine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazatchkine more than expected).
Fields of papers citing papers by Kazatchkine
This network shows the impact of papers produced by Kazatchkine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazatchkine. The network helps show where Kazatchkine may publish in the future.
Co-authors
The 25 scholars most cited alongside Kazatchkine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b. | 1979 | 293 |
| 2 | Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. | 1985 | 178 |
| 3 | Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A. | 1980 | 45 |
| 4 | Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. | 1989 | 45 |
| 5 | Immunoglobulins and the regulation of autoimmunity through the immune network. | 1996 | 32 |
| 6 | Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. | 1987 | 30 |
| 7 | Immunohistochemical analysis of C3 cleavage fragments, factor H, and the C5b-9 terminal complex of complement in de novo membranous glomerulonephritis occurring in patients with renal transplant. | 1986 | 22 |
| 8 | Induction of interleukin-1 during hemodialysis. | 1993 | 21 |
| 9 | Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). | 1990 | 18 |
| 10 | Idiotypic regulation of anti-factor VIII antibodies. | 2000 | 11 |
| 11 | Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases. | 1993 | 9 |
| 12 | 2000 | 8 | |
| 13 | Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect. | 1985 | 7 |
| 14 | The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy. | 1990 | 5 |
| 15 | Complement and Immunological Disease | 1988 | 4 |
| 16 | A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection. | 1996 | 4 |
| 17 | [Induction of interleukin-1 synthesis. A new criterion of biocompatibility of extracorporeal circuits]. | 1991 | 2 |
| 18 | Idiotypic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg). | 1992 | 2 |
| 19 | C3 receptor-mediated production and release of interleukin 1 by human monocytes. | 1989 | 1 |
| 20 | [Reversible hyperaluminemia induced by ingestion of didanosine in a patient under chronic hemodialysis]. | 1994 | 1 |
About Kazatchkine
Kazatchkine is a scholar working on Immunology, Hematology, Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology, having authored 20 papers that have together received 738 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (5 papers), Blood groups and transfusion (4 papers), Complement system in diseases (4 papers), T-cell and B-cell Immunology (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Hemophilia Treatment and Research (2 papers), Platelet Disorders and Treatments (2 papers) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Hematology (193 citations), Immunology (345 citations), Nephrology (66 citations), Microbiology (35 citations) and Genetics (57 citations). Kazatchkine has collaborated with scholars based in France and Netherlands. Frequent co-authors include Fearon Dt, Austen Kf, F Maillet, A Carpentier, Evelyne Fischer, Crh Wildevuur, Béatrice Descamps‐Latscha, N Hinglais, Chantal Mandet and J Bariéty. Their work appears in journals such as Clinical Nephrology, Scandinavian Journal of Immunology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.